Human umbilical cord blood stem cell transplantation for the treatment of chronic spinal cord injury: Electrophysiological changes and long-term efficacy

Neural Regeneration Research

Volumn 8, Issue 5, 2013, Pages 397-403

  Yao, Li Qing ^a   He, Chuan ^a   Zhao, Ying ^a   Wang, Ji Rong ^a   Tang, Mei ^a   Li, Jun ^a   Wu, Ying ^a   Ao, Li Juan ^a   Hu, Xiang ^b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b Shenzhen Beike Cell Engineering Research Institution Shenzhen   (China)

Author keywords

American spinal cord injury association score; Human umbilical cord blood stem cells; Neural regeneration; Neurogeneration; Neurological function; Paraplegia; Photographs containing paper; Safety; Secretion; Somatosensory evoked potentials; Spasm; Spinal cord injury; Transplantation

Indexed keywords

ADULT; AMERICAN SPINAL INJURY ASSOCIATION IMPAIRMENT SCALE; ARTICLE; AUTONOMIC NERVE; BLOOD CELL COUNT; CERVICAL SPINAL CORD INJURY; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ELECTROMYOGRAPHY; EVOKED SOMATOSENSORY RESPONSE; FEMALE; FEVER; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONONUCLEAR STEM CELL; MUSCLE SPASM; NUCLEAR MAGNETIC RESONANCE IMAGING; REHABILITATION; RETROSPECTIVE STUDY; SPINAL CORD REGENERATION; YOUNG ADULT;

EID: 84885724759     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.05.002     Document Type: Article

References (35)

1. Wyndaele M, Wyndaele JJ. Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? Spinal Cord. 2006;44(9):523-529.
2. Kwon BK, Stammers AM, Belanger LM, et al. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J Neurotrauma. 2010;27(4):669-682.
3. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg. 1991;75(1):15-26.
4. Dusart I, Schwab ME. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci. 1994;6(5):712-724.
5. Bracken MB, Holford TR. Neurological and functional status 1 year after acute spinal cord injury: estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III. J Neurosurg. 2002;96(3 Suppl): 259-266.
6. Kobylka P, Ivanyi P, Breur-Vriesendorp BS. Preservation of immunological and colony- forming capacities of long-term (15 years) cryopreserved cordblood cells. Transplantation. 1998;65(9):1275-1278.
7. Liu CH, Hwang SM. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine. 2005; 32(6):270-279.
8. Newman MB, Willing AE, Manresa JJ, et al. Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair. Exp Neurol. 2006; 199(1):201-208.
9. Neuhoff S, Moers J, Rieks M, et al. Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro. Exp Hematol. 2007;35(7):1119-1131.
10. Chua SJ, Bielecki R, Wong CJ, et al. Neural progenitors, neurons and oligodendrocytes from human umbilical cord blood cells in a serum-free, feeder free cell culture. Biochem Biophys Res Commun. 2009;379(2):217-221.
11. Chen N, Hudson JE, Walczak P, et al. Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural. Stem Cells. 2005; 23(10):1560-1570.
12. Lee MW, Moon YJ, Yang MS, et al. Neural differentiation of novel multipotent progenitor cells from cryopreserved human umbilical cord blood. Biochem Biophys Res Commun. 2007;358(2):637-643.
13. Ortiz-Gonzalez XR, Keene CD, Verfaillie CM, et al. Neural induction of adult bone marrow and umbilical cord stem cells. Curr Neurovasc Res. 2004;1(3):207-213.
14. Li JY, Christophersen NS, Hall V, et al. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci. 2008;31(3):146-153.
15. Sykova E, Jendelova P, Urdzi'Kova L, et al. Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair. Cell Mol Neurobiol. 2006;(7-8): 1113-1129.
16. Park HC, Shim YS, Ha Y, et al. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocytemacrophage colony stimulating factor. Tissue Eng. 2005;11(5-6):913-922.
17. Tator CH. Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations. Neurosurgery. 2006;59(5):957-982.
18. Stokic DS, Curt A. Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive evoked potentials in 39 patients. Spinal Cord. 2010;48(8):649.
19. McDonald JW, Belegu V. Demyelination and remyelination after spinal cord injury. Neurotrauma. 2006;23(3-4): 345-359.
20. McDonald JW. Repairing the damaged spinal cord: from stem cells to activity-based restoration therapies. Clin Neurosurg. 2004;51:207-227.
21. Becker D, Sadowsky CL, McDonald JW. Restoring function after spinal cord injury. Neurologist. 2003; 9(1):1-15.
22. Chua SJ, Bielecki R, Wong CJ, et al. Neural progenitors, neurons and oligodendrocytes from human umbilical cord blood cells in a serum-free, feederfree cell culture. Biochem Biophys Res Commun. 2009;379(2):217-221.
23. Chua SJ, Bielecki R, Yamanaka N, et al. The effect of umbilical cord blood cells on outcomes after experimental traumatic spinal cord injury. Spine. 2010;35(16):1520-1526.
24. Veeravalli KK, Dasari VR, Tsung AJ, et al. Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury. Neurobiol Dis. 2009;36(1):200-212.
25. Sykova E, Jendelova P, Urdzi'Kova L, et al. Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair. Cell Mol Neurobiol. 2006;26(7-8): 1113-1129.
26. Park HC, Shim YS, Ha Y, et al. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocytemacrophage colony stimulating factor. Tissue Eng. 2005;11(5-6):913-922.
27. Burns AS, Lee BS, Ditunno Jr JF, et al. Patient selection for clinical trials: the reliability of the early spinal cord injury examination. J Neurotrauma. 2003;20(5):477-482.
28. Marino RJ, Barros T, Biering-Sorensen F, et al. International standards for neurological classification of spinal cord injury. J Spinal Cord Med. 2003;26(Suppl 1): S50-56.
29. Ogawa Y, Sawamoto K, Miyata T, et al. Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J Neurosci Res. 2002;69(6): 925-933.
30. Sasaki M, Honmou O, Akiyama Y, et al. Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons. Glia. 2001;35(1): 26-34.
31. Liu S, Qu Y, Stewart TJ, et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A. 2000;97(11):6126-6131.
32. Burns AS, Ditunno JF. Establishing prognosis and maximizing functional outcomes after spinal cord injury: a review of current and future directions in rehabilitation management. Spine. 2001;26(24 Suppl):S137-145.
33. State Council of the People's Republic of China. Administrative Regulations on Medical Institution. 1994-09-01.
34. Yang WZ, Zhang Y, Wu F, et al. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. J Transl Med. 2010;(8):75-80.
35. Kirshblum SC, Memmo P, Kim N, et al. Comparision of the revised 2000 American Spinal Injury Association classification standards with the 1966 guidelines. Am J Phys Med Rehabili. 2002;81(7):502-505.